• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G158
Device Problems Failure to Capture (1081); High Capture Threshold (3266)
Patient Problems Syncope/Fainting (4411); Asystole (4442)
Event Date 01/08/2023
Event Type  Injury  
Event Description
It was reported that this patient presented to the hospital for asystole and syncope.Upon interrogation of this cardiac resynchronization therapy defibrillator (crt-d) it was found that there was loss of capture (loc) on the left ventricular (lv) lead as well as high capture thresholds on the right ventricular (rv) lead.Technical services (ts) analyzed presenting electrogram (egm) and discussed reprogramming options with boston scientific field sales representative.The lv lead is a non-boston scientific product.Threshold outputs were increased by programming.No additional adverse patient effects were reported.Currently, this crt-d system remains in service.
 
Event Description
It was reported that this patient presented to the hospital for asystole and syncope.Upon interrogation of this cardiac resynchronization therapy defibrillator (crt-d) it was found that there was loss of capture (loc) on the left ventricular (lv) lead as well as high capture thresholds on the right ventricular (rv) lead.Technical services (ts) analyzed presenting electrogram (egm) and discussed reprogramming options with boston scientific field sales representative.The lv lead is a non-boston scientific product.Threshold outputs were increased by programming.No additional adverse patient effects were reported.Currently, this crt-d system remains in service.According to additional information, this crt-d was explanted and replaced with a new device.No additional adverse patient effects were reported.As of today, this product has not been received by boston scientific for further evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16443663
MDR Text Key310250631
Report Number2124215-2023-09000
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/06/2017
Device Model NumberG158
Device Catalogue NumberG158
Device Lot Number137710
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age67 YR
Patient SexMale
-
-